
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hyperuricemia and Incident Heart Failure
Eswar Krishnan
Circulation Heart Failure (2009) Vol. 2, Iss. 6, pp. 556-562
Open Access | Times Cited: 117
Eswar Krishnan
Circulation Heart Failure (2009) Vol. 2, Iss. 6, pp. 556-562
Open Access | Times Cited: 117
Showing 1-25 of 117 citing articles:
Reactive oxygen species in cardiovascular disease
Koichi Sugamura, John F. Keaney
Free Radical Biology and Medicine (2011) Vol. 51, Iss. 5, pp. 978-992
Open Access | Times Cited: 735
Koichi Sugamura, John F. Keaney
Free Radical Biology and Medicine (2011) Vol. 51, Iss. 5, pp. 978-992
Open Access | Times Cited: 735
Uric acid and cardiovascular disease
Gjin Ndrepepa
Clinica Chimica Acta (2018) Vol. 484, pp. 150-163
Closed Access | Times Cited: 404
Gjin Ndrepepa
Clinica Chimica Acta (2018) Vol. 484, pp. 150-163
Closed Access | Times Cited: 404
Uric acid and risk of heart failure: a systematic review and meta‐analysis
He Huang, Bao‐Tao Huang, Yulin Li, et al.
European Journal of Heart Failure (2013) Vol. 16, Iss. 1, pp. 15-24
Closed Access | Times Cited: 293
He Huang, Bao‐Tao Huang, Yulin Li, et al.
European Journal of Heart Failure (2013) Vol. 16, Iss. 1, pp. 15-24
Closed Access | Times Cited: 293
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Claudio Borghi, Enrico Agabiti‐Rosei, Richard J. Johnson, et al.
European Journal of Internal Medicine (2020) Vol. 80, pp. 1-11
Closed Access | Times Cited: 290
Claudio Borghi, Enrico Agabiti‐Rosei, Richard J. Johnson, et al.
European Journal of Internal Medicine (2020) Vol. 80, pp. 1-11
Closed Access | Times Cited: 290
Uric acid and cardiovascular disease: A clinical review
Yuichi Saito, Atsushi Tanaka, Koichi Node, et al.
Journal of Cardiology (2020) Vol. 78, Iss. 1, pp. 51-57
Open Access | Times Cited: 255
Yuichi Saito, Atsushi Tanaka, Koichi Node, et al.
Journal of Cardiology (2020) Vol. 78, Iss. 1, pp. 51-57
Open Access | Times Cited: 255
Established and Emerging Roles of Biomarkers in Heart Failure
Nasrien E. Ibrahim, James L. Januzzi
Circulation Research (2018) Vol. 123, Iss. 5, pp. 614-629
Open Access | Times Cited: 253
Nasrien E. Ibrahim, James L. Januzzi
Circulation Research (2018) Vol. 123, Iss. 5, pp. 614-629
Open Access | Times Cited: 253
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk
Claudio Borghi, Davide Agnoletti, Arrigo F.G. Cicero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1927-1936
Open Access | Times Cited: 97
Claudio Borghi, Davide Agnoletti, Arrigo F.G. Cicero, et al.
Hypertension (2022) Vol. 79, Iss. 9, pp. 1927-1936
Open Access | Times Cited: 97
Uric acid in health and disease: From physiological functions to pathogenic mechanisms
Shijie Wen, Hiroshi Arakawa, Ikumi Tamai
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108615-108615
Closed Access | Times Cited: 70
Shijie Wen, Hiroshi Arakawa, Ikumi Tamai
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108615-108615
Closed Access | Times Cited: 70
Update in uric acid, hypertension, and cardiovascular diseases
Masanari Kuwabara, Takahide Kodama, Ryusuke Ae, et al.
Hypertension Research (2023) Vol. 46, Iss. 7, pp. 1714-1726
Closed Access | Times Cited: 46
Masanari Kuwabara, Takahide Kodama, Ryusuke Ae, et al.
Hypertension Research (2023) Vol. 46, Iss. 7, pp. 1714-1726
Closed Access | Times Cited: 46
Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
Sheena N. Ramasamy, Cameron S. Korb-Wells, Diluk R. W. Kannangara, et al.
Drug Safety (2013) Vol. 36, Iss. 10, pp. 953-980
Closed Access | Times Cited: 167
Sheena N. Ramasamy, Cameron S. Korb-Wells, Diluk R. W. Kannangara, et al.
Drug Safety (2013) Vol. 36, Iss. 10, pp. 953-980
Closed Access | Times Cited: 167
Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study
Tanya E. Keenan, Wei Zhao, Asif Rasheed, et al.
Journal of the American College of Cardiology (2016) Vol. 67, Iss. 4, pp. 407-416
Open Access | Times Cited: 162
Tanya E. Keenan, Wei Zhao, Asif Rasheed, et al.
Journal of the American College of Cardiology (2016) Vol. 67, Iss. 4, pp. 407-416
Open Access | Times Cited: 162
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project
Alessandro Maloberti, Cristina Giannattasio, Michele Bombelli, et al.
High Blood Pressure & Cardiovascular Prevention (2020) Vol. 27, Iss. 2, pp. 121-128
Closed Access | Times Cited: 128
Alessandro Maloberti, Cristina Giannattasio, Michele Bombelli, et al.
High Blood Pressure & Cardiovascular Prevention (2020) Vol. 27, Iss. 2, pp. 121-128
Closed Access | Times Cited: 128
Biomarkers in heart failure: the past, current and future
Sarhene Michael, Yili Wang, Jing Wei, et al.
Heart Failure Reviews (2019) Vol. 24, Iss. 6, pp. 867-903
Closed Access | Times Cited: 110
Sarhene Michael, Yili Wang, Jing Wei, et al.
Heart Failure Reviews (2019) Vol. 24, Iss. 6, pp. 867-903
Closed Access | Times Cited: 110
Uric Acid and Cardiovascular Disease: An Update
María Lorenza Muiesan, Claudia Agabiti-Rosei, Anna Paini, et al.
European Cardiology Review (2016) Vol. 11, Iss. 1, pp. 54-54
Open Access | Times Cited: 109
María Lorenza Muiesan, Claudia Agabiti-Rosei, Anna Paini, et al.
European Cardiology Review (2016) Vol. 11, Iss. 1, pp. 54-54
Open Access | Times Cited: 109
Serum Uric Acid and Mortality Form Cardiovascular Disease: EPOCH-JAPAN Study
Wen Zhang, Hiroyasu Iso, Yoshitaka Murakami, et al.
Journal of Atherosclerosis and Thrombosis (2016) Vol. 23, Iss. 6, pp. 692-703
Open Access | Times Cited: 102
Wen Zhang, Hiroyasu Iso, Yoshitaka Murakami, et al.
Journal of Atherosclerosis and Thrombosis (2016) Vol. 23, Iss. 6, pp. 692-703
Open Access | Times Cited: 102
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5863-5863
Open Access | Times Cited: 77
Giuseppe Palmiero, Arturo Cesaro, Erica Vetrano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5863-5863
Open Access | Times Cited: 77
Hyperuricemia and gout increased the risk of long-term mortality in patients with heart failure: insights from the National Health and Nutrition Examination Survey
Yingdong Han, Yu Cao, Xinxin Han, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Yingdong Han, Yu Cao, Xinxin Han, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Novel Oxidative Stress Biomarkers with Risk Prognosis Values in Heart Failure
Mah Lee Ng, Ang Xu, Kwan Yi Yap, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 917-917
Open Access | Times Cited: 30
Mah Lee Ng, Ang Xu, Kwan Yi Yap, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 917-917
Open Access | Times Cited: 30
Large-scale cross-ancestry genome-wide meta-analysis of serum urate
Chamlee Cho, Beomsu Kim, Dan Say Kim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Chamlee Cho, Beomsu Kim, Dan Say Kim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Gout and the risk for incident heart failure and systolic dysfunction
Eswar Krishnan
BMJ Open (2012) Vol. 2, Iss. 1, pp. e000282-e000282
Open Access | Times Cited: 91
Eswar Krishnan
BMJ Open (2012) Vol. 2, Iss. 1, pp. e000282-e000282
Open Access | Times Cited: 91
The relationship between body mass index and uric acid: a study on Japanese adult twins
Kentaro Tanaka, Soshiro Ogata, Haruka Tanaka, et al.
Environmental Health and Preventive Medicine (2015) Vol. 20, Iss. 5, pp. 347-353
Open Access | Times Cited: 76
Kentaro Tanaka, Soshiro Ogata, Haruka Tanaka, et al.
Environmental Health and Preventive Medicine (2015) Vol. 20, Iss. 5, pp. 347-353
Open Access | Times Cited: 76
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study
María Lorenza Muiesan, Massimo Salvetti, Agostino Virdis, et al.
Journal of Hypertension (2020) Vol. 39, Iss. 1, pp. 62-69
Closed Access | Times Cited: 64
María Lorenza Muiesan, Massimo Salvetti, Agostino Virdis, et al.
Journal of Hypertension (2020) Vol. 39, Iss. 1, pp. 62-69
Closed Access | Times Cited: 64
Uric acid and cardiometabolic diseases
Seung Jae Lee, Byeong Kil Oh, Ki‐Chul Sung
Clinical Hypertension (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 57
Seung Jae Lee, Byeong Kil Oh, Ki‐Chul Sung
Clinical Hypertension (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 57
Xanthine oxidase inhibitors: patent landscape and clinical development (2015–2020)
Jatinder Singh, Preet Mohinder Singh Bedi, Harbinder Singh, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 10, pp. 769-780
Closed Access | Times Cited: 52
Jatinder Singh, Preet Mohinder Singh Bedi, Harbinder Singh, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 10, pp. 769-780
Closed Access | Times Cited: 52
Clinical Implications of Uric Acid in Heart Failure: A Comprehensive Review
Marko Kumrić, Josip A. Borovac, Tina Tičinović Kurir, et al.
Life (2021) Vol. 11, Iss. 1, pp. 53-53
Open Access | Times Cited: 34
Marko Kumrić, Josip A. Borovac, Tina Tičinović Kurir, et al.
Life (2021) Vol. 11, Iss. 1, pp. 53-53
Open Access | Times Cited: 34